TCL Archive Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies November 28, 2014
TCL Archive Aetna No Longer To Cover HDC/BMT For Breast Cancer Outside Of Clinical Trials. February 25, 2000